Ebola NC: Local Response – Global Impact
A forum developed in partnership between the North Carolina Biotechnology Center and the Triangle Global Health Consortium
When: Dec 08, 2014
Time: 8:00 AM – 1:00 PM
Where: North Carolina Biotechnology Center
Ebola represents one of several viral hemorrhagic fevers that can cause severe illness in humans often leading to death. The recent Ebola outbreak in West Africa has resulted in an unprecedented number of Ebola cases with widespread transmission in Guinea, Sierra Leone and Liberia. Moreover, travel associated cases have occurred in Mali and Senegal and cases of limited transmission have occurred in the United States, Spain and Nigeria. The highly infectious nature of the Ebola virus and the rate of morbidity associated with infection have elicited a global response to treat infected patients and to prevent further spread of the virus.
Here in North Carolina public health officials are coordinating with federal agencies such as the Centers for Disease Control, the National Institute of Allergy and Infectious Disease, the Department of Homeland Security and others developing prevention, detection and treatment strategies as well as comprehensive standards for patient care. In addition, several North Carolina companies are directly involved in developing therapies, providing treatments, leading clinical trials or preparing to manufacture Ebola vaccines or therapies. The forum will address the global challenge of the Ebola outbreak and coordination underway among responding ministries, government agencies, non-governmental organizations and clinical practitioners. Furthermore, North Carolina’s preparation for the isolation and treatment of infected individuals that travel to North Carolina as well as the state’s readiness for protecting citizens from exposure will be addressed. Finally, the forum will also highlight pharmaceutical and biotechnology companies in our state that are responding to the crisis.
Register Now – space is limited.